Blockchain Registration Transaction Record

GeoVax to Host Conference Call to Discuss 2024 Financial Results and Corporate Update

GeoVax Labs, Inc. will report 2024 financial results and host a conference call to discuss corporate updates. Learn about the clinical-stage biotechnology company's focus on developing vaccines and therapies for cancer and infectious diseases.

GeoVax to Host Conference Call to Discuss 2024 Financial Results and Corporate Update

This news matters as it provides investors and stakeholders with an opportunity to learn about GeoVax's financial performance and corporate developments. It also highlights the company's focus on developing innovative vaccines and therapies for infectious diseases and solid tumor cancers, showcasing its commitment to advancing healthcare solutions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x782e6c1b97ef09657dac17e782d73e19bb6f19132fa875460f14f7cdbbf8c4df
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintbakeC3GB-070c1985ef6747b349074d89a9ea7389